Keith Katkin - Sep 30, 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Sep 30, 2022
Transactions value $
-$69,534
Form type
4
Date filed
10/4/2022, 05:49 PM
Previous filing
Apr 5, 2022
Next filing
Oct 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $23K +2.91K +9.11% $7.88 34.9K Sep 30, 2022 Direct
transaction SNDX Common Stock Sale -$73.1K -2.91K -8.35% $25.07 32K Sep 30, 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $5.78K +647 +2.02% $8.93 32.6K Sep 30, 2022 Direct
transaction SNDX Common Stock Sale -$16.2K -647 -1.98% $25.07 32K Sep 30, 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $1.32K +167 +0.52% $7.88 32.2K Oct 3, 2022 Direct
transaction SNDX Common Stock Sale -$4.18K -167 -0.52% $25.00 32K Oct 3, 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $116 +13 +0.04% $8.93 32K Oct 3, 2022 Direct
transaction SNDX Common Stock Sale -$325 -13 -0.04% $25.00 32K Oct 3, 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $1.08K +137 +0.43% $7.88 32.1K Oct 4, 2022 Direct
transaction SNDX Common Stock Sale -$3.43K -137 -0.43% $25.00 32K Oct 4, 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $1.99K +223 +0.7% $8.93 32.2K Oct 4, 2022 Direct
transaction SNDX Common Stock Sale -$5.58K -223 -0.69% $25.00 32K Oct 4, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -647 -100% $0.00* 0 Sep 30, 2022 Common Stock 647 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -2.91K -100% $0.00* 0 Sep 30, 2022 Common Stock 2.91K $7.88 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -13 -100% $0.00* 0 Oct 3, 2022 Common Stock 13 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -167 -100% $0.00* 0 Oct 3, 2022 Common Stock 167 $7.88 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -223 -100% $0.00* 0 Oct 4, 2022 Common Stock 223 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -137 -100% $0.00* 0 Oct 4, 2022 Common Stock 137 $7.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $25.00 to $25.215.
F3 The sale price was $25.00.
F4 This option is fully vested.